Catalyst
Slingshot members are tracking this event:
Phase 3 Data from Second Epidiolex Lennox-Gastaut Syndrome Study due H2 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GWPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 26, 2016
Occurred Source:
https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-announces-second-positive-phase-3-pivotal-trial-epidiolex
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Data, Dravet Syndrome, Epilepsy, Epidiolex
